Activation of AMP-activated protein kinase prevents TGF-β1-induced epithelial-mesenchymal transition and myofibroblast activation.

[1]  J. B. Lopes de Faria,et al.  Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4/TGFβ-1 signaling. , 2014, The Journal of nutritional biochemistry.

[2]  A. Eid,et al.  Nox4 NADPH Oxidase Mediates Peroxynitrite-dependent Uncoupling of Endothelial Nitric-oxide Synthase and Fibronectin Expression in Response to Angiotensin II , 2013, The Journal of Biological Chemistry.

[3]  A. Eid,et al.  Sestrin 2 and AMPK Connect Hyperglycemia to Nox4-Dependent Endothelial Nitric Oxide Synthase Uncoupling and Matrix Protein Expression , 2013, Molecular and Cellular Biology.

[4]  A. J. Valente,et al.  Tuberin inhibits production of the matrix protein fibronectin in diabetes. , 2012, Journal of the American Society of Nephrology : JASN.

[5]  S. I. Park,et al.  AMP‐activated protein kinase inhibits TGF‐β‐induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300 , 2012, Journal of cellular physiology.

[6]  W. Yang,et al.  Albumin-induced epithelial-mesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate. , 2011, American journal of physiology. Renal physiology.

[7]  G. Tesch,et al.  Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. , 2011, American journal of physiology. Renal physiology.

[8]  B. Viollet,et al.  AMPK as a therapeutic target in renal cell carcinoma , 2010, Cancer biology & therapy.

[9]  Jianguo Song,et al.  AMP-activated protein kinase is required for induction of apoptosis and epithelial-to-mesenchymal transition. , 2010, Cellular signalling.

[10]  H. Abboud,et al.  AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes* , 2010, The Journal of Biological Chemistry.

[11]  Youhua Liu.  New insights into epithelial-mesenchymal transition in kidney fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[12]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[13]  K. Inoki,et al.  The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. , 2009, Biochemical and biophysical research communications.

[14]  Gaochao Zhou,et al.  AMPK: an emerging drug target for diabetes and the metabolic syndrome. , 2009, Cell metabolism.

[15]  J. Suttles,et al.  Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype1 , 2008, The Journal of Immunology.

[16]  M. Bendayan,et al.  Adiponectin stimulates phosphorylation of AMP-activated protein kinase α in renal glomeruli , 2008, Journal of Molecular Histology.

[17]  G. Wildey,et al.  TGFβ‐mediated BIM expression and apoptosis are regulated through SMAD3‐dependent expression of the MAPK phosphatase MKP2 , 2008, EMBO reports.

[18]  A. Eid,et al.  Nox4 NAD(P)H Oxidase Mediates Src-dependent Tyrosine Phosphorylation of PDK-1 in Response to Angiotensin II , 2008, Journal of Biological Chemistry.

[19]  B. Manning,et al.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.

[20]  B. Viollet,et al.  AMP-activated Protein Kinase Inhibits Transforming Growth Factor-β-induced Smad3-dependent Transcription and Myofibroblast Transdifferentiation* , 2008, Journal of Biological Chemistry.

[21]  Bernhard Schmierer,et al.  TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.

[22]  S. Okamoto,et al.  Leptin Stimulates Fatty Acid Oxidation and Peroxisome Proliferator-Activated Receptor α Gene Expression in Mouse C2C12 Myoblasts by Changing the Subcellular Localization of the α2 Form of AMP-Activated Protein Kinase , 2007, Molecular and Cellular Biology.

[23]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[24]  B. Viollet,et al.  A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. , 2007, American journal of physiology. Renal physiology.

[25]  D. Féliers,et al.  High Glucose, High Insulin, and Their Combination Rapidly Induce Laminin-β1 Synthesis by Regulation of mRNA Translation in Renal Epithelial Cells , 2007, Diabetes.

[26]  D. Féliers,et al.  mRNA translation: unexplored territory in renal science. , 2006, Journal of the American Society of Nephrology : JASN.

[27]  G. Rutter,et al.  Expanding role of AMPK in endocrinology , 2006, Trends in Endocrinology & Metabolism.

[28]  H. Esumi,et al.  Involvement of Transforming Growth Factor-β1 Signaling in Hypoxia-induced Tolerance to Glucose Starvation* , 2005, Journal of Biological Chemistry.

[29]  A. Means,et al.  The Ca2+/Calmodulin-dependent Protein Kinase Kinases Are AMP-activated Protein Kinase Kinases* , 2005, Journal of Biological Chemistry.

[30]  R. Heath,et al.  Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. , 2005, Cell metabolism.

[31]  A. Edelman,et al.  Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. , 2005, Cell metabolism.

[32]  K. Isshiki,et al.  N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. , 2005, Diabetes.

[33]  N. Ruderman,et al.  AMPK, the metabolic syndrome and cancer. , 2005, Trends in pharmacological sciences.

[34]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[35]  H. Ha,et al.  Reactive oxygen species and matrix remodeling in diabetic kidney. , 2003, Journal of the American Society of Nephrology : JASN.

[36]  H. Lan.  Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells , 2003, Current opinion in nephrology and hypertension.

[37]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[38]  M. Rastaldi,et al.  Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. , 2002, Kidney international.

[39]  L. Goodyear,et al.  Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes. , 2002, Current drug targets. Immune, endocrine and metabolic disorders.

[40]  K. Sharma,et al.  Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Cooper,et al.  The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? , 1999, Kidney international.

[42]  A. Prescott,et al.  AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. , 1998, The Biochemical journal.

[43]  M. Bryckaert,et al.  Transforming growth factor beta 1 inhibits mitogen-activated protein kinase induced by basic fibroblast growth factor in smooth muscle cells. , 1996, The Biochemical journal.

[44]  M. Sporn,et al.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Stephen P. Higgins,et al.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis , 2011, Cell and Tissue Research.

[46]  A. Gruzman,et al.  Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations. , 2009, The review of diabetic studies : RDS.

[47]  David Carling,et al.  The AMP-activated protein kinase cascade--a unifying system for energy control. , 2004, Trends in biochemical sciences.